Clinical trial
HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
NCT00000799 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- April 30, 1996
- Enrollment
- 100
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.